Back
Akebia Therapeutics Vs. Belite Bio Industry Stock Comparison
Sell
29
AKBA
Akebia Therapeutics
Last Price:
$1.56
Seasonality Move:
-12.09%
Buy
58
BLTE
Belite Bio
Last Price:
$70.10
Seasonality Move:
-21.45%
Sell
29
Akebia Therapeutics (AKBA)
is a Sell
Is Akebia Therapeutics a Buy, Sell or Hold?
-
The current Akebia Therapeutics [AKBA] share price is $1.93. The Score for AKBA is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
-
AKBA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
58
Belite Bio (BLTE)
is a Buy
Is Belite Bio a Buy, Sell or Hold?
-
The current Belite Bio [BLTE] share price is $69.48. The Score for BLTE is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
-
BLTE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
AKBA Stock Price Chart
What is Akebia Therapeutics's stock price today?
-
The Akebia Therapeutics share price today is $1.93Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKBA is experiencing slight selling pressure.
BLTE Stock Price Chart
What is Belite Bio's stock price today?
-
The Belite Bio share price today is $69.48Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BLTE is experiencing slight selling pressure.
AKBA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.05 | Sell |
Relative Strength Index (14 RSI): | 48.89 | Sell |
Chaikin Money Flow: | -1739832 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.84 - 2.12) | Sell |
Bollinger Bands (100): | (1.68 - 2.14) | Buy |
BLTE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.98 | Buy |
Relative Strength Index (14 RSI): | 75.22 | Buy |
Chaikin Money Flow: | -7345 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (54.78 - 62.16) | Buy |
Bollinger Bands (100): | (55.33 - 72.05) | Buy |
AKBA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.88 | Buy |
20-day SMA: | 1.94 | Sell |
50-day SMA: | 2.02 | Sell |
200-day SMA: | 1.58 | Buy |
8-day EMA: | 1.9 | Buy |
20-day EMA: | 1.94 | Sell |
50-day EMA: | 1.96 | Sell |
200-day EMA: | 1.7 | Buy |
BLTE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 62.13 | Buy |
20-day SMA: | 58.56 | Buy |
50-day SMA: | 58.59 | Buy |
200-day SMA: | 56.19 | Buy |
8-day EMA: | 63.46 | Buy |
20-day EMA: | 60.35 | Buy |
50-day EMA: | 59.89 | Buy |
200-day EMA: | 56.07 | Buy |
Akebia Therapeutics Earnings Growth & AKBA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.13 per share, and an increase next year of $0.24 per share.
Belite Bio Earnings Growth & BLTE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.18 per share, and an increase next year of $0.98 per share.
Akebia Therapeutics Technical Analysis
Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Belite Bio Technical Analysis
Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |